Autolus Therapeutics Reports Third Quarter 2021 Financial Results and Operational Progress

NEXT STORY
Agios Reports Business Highlights and Third Quarter 2021 Financial Results
PREV STORY
Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physician Fee Schedule Final Rule
Subscribe to PM360
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

Athenex to Present at UBS Global Healthcare Conference

BUFFALO, N.Y., May 21, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Closing of $20 Million Underwritten Offering

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News

Vascular Biogenics Ltd. Announces $24 Million Registered Direct Offering

TEL AVIV, Israel, June 07, 2016 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” ...

author_avatar
NASDAQ Market News